Strategic Manipulation of Tumor Antigens to Enhance Immunogenicity
Abstract
Systemic chemotherapy including high dose chemotherapy with stem cell rescue frequently induces responses in women with metastatic breast cancer Unfortunately, disease often recurs due to the persistence of chemotherapy resistant tumor cells. The immune system can effectively target and kill chemotherapy resistant tumor cells. Tumor associated antigens particularly antigens derived from the Her-2/neu oncogene can be recognized in breast cancer. Strategies to enhance immune recognition of these antigens may provide a therapeutic benefit. Recent studies indicate that the N-terminal flanking region of the invariant chain peptide termed CLIP has superagonisitc properties. The central hypothesis of this research project is that the N-terminal flanking region of CLIP can augment the immunogenicity of cryptic 'self' peptide epitopes from Her-2/neu. Ongoing studies indicate that immunization with chimeric constructs of an MHC class II binding peptide antigen from Her-2/neu presented on tumor cells or on dendritic cells in concert with an MHC class I binding peptide from Her-2/neu induces a potent cytolytic T cell response and protective antitumor immunity. Further analysis of the cell-mediated immune mechanisms reveals that immunization with the chimeric Her-2/neu construct triggers a type 1 cytokine (IL-2, IFN(sub gamma) T helper cell response. The type 1 cytokine response may underlie the induction of protective antitumor immunity allowing for the clonal amplification of effector T cells and inducing upregulation of target antigens on the tumor cell. Importantly, immunization with the chimeric construct appears to enhance antitumor immunity even in the presence of growing tumors. Augmenting the immune response to tumor associated antigens will enhance therapeutic strategies for the treatment of breast cancer.
Document Details
- Document Type
- Technical Report
- Publication Date
- Sep 01, 2001
- Accession Number
- ADA403419
Entities
People
- Allan D. Hess
Organizations
- Johns Hopkins University